2015 CMHC Preliminary Program Agenda
10th Annual Cardiometabolic Health Congress
Learn Why Attending the Cardiometabolic Health Congress is Important to Your Practice
Co-Chairs Christie M. Ballantyne, MD and Robert H. Eckel, MD discuss how the CMHC provides the most comprehensive CME program addressing the intertwined epidemics of cardiovascular and metabolic diseases, translating the latest science to solutions for front-line clinicians.
Register NowWednesday, October 21, 2015
Wednesday - Thursday - Friday - Saturday
On a mobile device? Drag the schedule to the right to view all the event details.
PRE-CONFERENCE ACTIVITIES
| 12:30pm - 2:00pm | RepathaTM (evolocumab): Product Overview Sponsored by Amgen, Inc. |
James A. Underberg, MD |
| 2:00pm - 3:15pm | Clinical Management of Inflammatory Responses in Vascular Patients Sponsored by Metagenics |
Marlene Grenon, MD John Troup, PhD |
| 3:15pm - 4:30pm | RNA-targeting Antisense Technology Explained Sponsored by Genzyme, a Sanofi company |
Richard S. Geary, PhD |
| 4:30pm - 5:45pm | Advancing Knowledge of Hypertriglyceridemia Sponsored by AstraZeneca |
James M. Falko, MD |
| 5:45pm - 7:00pm | Strategies for Effective Weight Management Sponsored by Novo Nordisk, Inc. |
Nikhil Dhurandhar |
Thursday, October 22, 2015
On a mobile device? Drag the schedule to the right to view all the event details.
| 6:30am - 8:00am | CME Dialectic Breakfast Symposium A Current Controversies and Novel Insights into Lipid Management:The Good, the Bad and the Ugly? Supported by an educational grant from Lilly |
Michael H. Davidson, MD (Chair) Sergio Fazio, MD; Robert S. Rosenson, MD |
| 6:45am - 7:45am | CME Expert Roundtable Breakfast Workshop Symposium B Hypertriglyceridemia - A Neglected CVD Risk Factor:Getting to the Heart of the Matter Supported by an educational grant from AstraZeneca |
Christie M. Ballantyne, MD (Chair) Henry N. Ginsberg, MD Michael Miller, MD |
SESSION I: DYSLIPIDEMIA, ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE RISK REDUCTION
| 8:00am - 8:10am | General Sessions Begin: Opening Remarks | Christie M. Ballantyne, MD |
| 8:10am - 8:40am |
Keynote SessionPCSK9: From Gene to Therapy |
Jay D. Horton, MD |
| 8:40am - 9:05am | Triglycerides & HDL: Where Are We Now and What's on the Horizon? | Henry N. Ginsberg, MD |
| 9:05am - 9:35am | IMPROVE-IT: How Do We Go Forward with the Guidelines? | Moderator: Christie M. Ballantyne, MD Discussants: Jennifer G. Robinson, MD, MPH Roger S. Blumenthal, MD |
| 9:35am - 10:00am | Integrating Biomarkers and Imaging for CV Risk Assessment and Treatment | Matthew J. Budoff, MD |
| 10:00am - 11:00am | Morning Break/Exhibitor Showcase |
|
| 11:00am - 11:45am | Clinical Controversies in Lipid Management: Case-Based Presentations & Discussion | Moderator: Christie M. Ballantyne, MD Presenters & Discussants: Roger S. Blumenthal, MD Robert H. Eckel, MD Henry N. Ginsberg, MD Jennifer G. Robinson, MD, MPH |
| 11:45am - 1:45pm | CME Deep Dive Lunch Symposium A Going Beyond "Eat Less and Move More": Proactive and Progressive Approaches In Obesity ManagementSupported by educational grants from Novo Nordisk, Inc. and Takeda Pharmaceuticals U.S.A., Inc. |
Robert H. Eckel, MD (Chair) Harold E. Bays, MD Samuel Klein, MD Deborah Bade Horn, DO, MPH |
| 11:45am - 1:45pm | A Closer Look at CV Outcomes for Type 2 Diabetes Therapies: Implications for Patient Care Supported by an educational grant from Merck & Co., Inc. |
Jay S. Skyler, MD (Chair) Deepak L. Bhatt, MD, MPH Jennifer B. Green, MD Darren K. McGuire, MD, MHSc |
| 11:45am - 1:45pm | The Faces of Lipodystrophy: Contemporary Diagnosis and Management Strategies for an Unrecognized Cardiometabolic Disorder Supported by an educational grant from Aegerion Pharmaceuticals, Inc. Endorsed by Lipodystrophy United |
Abhimanyu Garg, MD (Chair) Elaine K. Cochran, CRNP Vinaya Simha, MBBS, MD Dwanna Swan, PhD |
| 1:45pm - 2:45pm | Expert Debates in Antithrombotic Therapy | Moderator: Deepak L. Bhatt, MD, MPH Presenters & Discussants: John Eikelboom, MBBS, MSc A. Michael Lincoff, MD |
| 2:45pm - 3:45pm | Afternoon Break/Exhibitor Showcase |
|
| 3:45pm - 5:00pm | Late-Breaking Clinical Trials and FDA Update | Presenters & Discussants: Christie M. Ballantyne, MD Deepak L. Bhatt, MD, MPH Robert H. Eckel, MD Keith C. Ferdinand, MD Jay S. Skyler, MD |
| 5:00pm | Closing Remarks | Christie M. Ballantyne, MD |
| 5:00pm - 6:00pm | Lp-PLA2 Activity Testing: An Advanced New Biomarker for CHD Management Sponsored by Diadexus, Inc. |
Mary Cushman, MD, MSc Leslie Donato, PhD Peter McCullough, MD, MPH Michelle O'Donoghue, MD |
| 5:00pm - 6:00pm | Understanding the Role of VASCEPA® (icosapent ethyl) as Add-on to Statins in Patients With Persistent High Triglyceride Levels (≥200 to <500 mg/dL) Sponsored by Amarin Pharma |
Eliot Brinton, MD |
| 6:00pm - 7:00pm | Welcome Reception/Exhibitor Showcase |
|
| 7:00pm - 9:00pm | CME Deep Dive Dinner Symposium Novel Therapies for LDL-C Lowering in the Fight Against Residual ASCVD RiskSupported by educational grants from Genzyme, a Sanofi company, sanofi-aventis U.S., and Regeneron Pharmaceuticals |
Christie M. Ballantyne, MD (Chair) Jay D. Horton, MD Patrick M. Moriarty, MD Jennifer G. Robinson, MD, MPH |
Friday, October 23, 2015
On a mobile device? Drag the schedule to the right to view all the event details.
| 6:30am - 8:00am | A Conversation with the Experts: New Scientific, Genetic, and Clinical Insights into the Management of Triglycerides Supported by an educational grant from Amarin Pharma, Inc. |
Peter H. Jones, MD (Chair) Sekar Kathiresan, MD R. Preston Mason, MBA, PhD Howard S. Weintraub, MD |
| 6:45am - 7:45am | CME Expert Roundtable Breakfast Workshop Symposium B Improving CVD Risk Reduction in African Americans: A Call to ActionSupported by an educational grant from Arbor Pharmaceuticals |
Clyde W. Yancy, MD, MSc, MACP (Chair) Keith C. Ferdinand, MD Gary Puckrein, PhD |
SESSION II: HYPERTENSION AND CARDIO-RENAL SYNDROME
| 8:00am - 8:05am | General Sessions Begin: Opening Remarks | George L. Bakris, MD |
| 8:05am - 8:30am | Management of Resistant Hypertension: An Update | George L. Bakris, MD |
| 8:30am - 8:55am | Addressing the Unmet Need in Hyperkalemia Treatment | Rajiv Agarwal, MD |
| 8:55am - 9:20am | Prevention and Treatment of Heart Failure: Novel Therapies | Clyde W. Yancy, MD, MSc, MACP |
| 9:20am - 9:45am | Diabetes, Kidney Disease and Hypertension | Allan J. Collins, MD |
| 9:45am - 10:15am | CVD Risk Reduction in Patients with Renal Disease: Cases, Panel Discussion | Moderator: George L. Bakris, MD Discussants: Rajiv Agarwal, MD Allan J. Collins, MD Clyde W. Yancy, MD, MSc, MACP |
| 10:15am - 11:15am | Morning Break/Exhibit Showcase |
SESSION III: LIFESTYLE AND OBESITY MANAGEMENT
| 11:15am - 11:45am |
Keynote SessionLeptin and the Treatment of Obesity and Diabetes |
Jeffrey M. Friedman, MD, PhD |
| 11:45am - 1:45pm | The Role of Combination Therapies in Early, Intensive Treatment of Type 2 Diabetes: Patient-Centered Approaches to Improve Glucose Control and Reduce Cardiometabolic Risk Factors Supported by an educational grant from AstraZeneca |
John B. Buse, MD, PhD (Chair) Lawrence Blonde, MD Samuel Dagogo-Jack, MD Carol H. Wysham, MD |
| 11:45am - 1:45pm | New Insights into the Prevention and Clinical Management of Hyperkalemia Supported by an educational grant from Relypsa, Inc. |
George L. Bakris, MD (Chair) Bertram Pitt, MD Matthew R. Weir, MD |
| 11:45am - 1:45pm | CME Clinical Advances Spotlight Lunch Symposium C Advances in LDL Lowering: A Focus on PCSK9 Inhibitors'Journey from Genetics to Clinical Practice Supported by an educational grant from Amgen, Inc. |
Marc S. Sabatine, MD (Chair) Seth J. Baum, MD Michael J. Koren, MD James A. Underberg, MD |
| 1:45pm - 2:15pm |
Keynote SessionThe Science Behind Heart Healthy Nutrition and Weight Management |
Frank M. Sacks, MD |
| 2:15pm - 2:40pm | Pharmacotherapy in the Management of Obesity: New Drugs and Emerging Targets |
Samuel Klein, MD |
| 2:40pm - 3:25pm | Afternoon Break/Exhibit Showcase |
|
| 3:25pm - 4:05pm | Long-Term and Metabolic Effects of Bariatric Surgery | Lee M. Kaplan, MD, PhD Francesco Rubino, MD |
| 4:05pm - 4:30pm | Behavior Change: From Compliance to Collaboration | Martha M. Funnell, MS, RN, CDE |
| 4:30pm - 5:00pm | Obesity & Lifestyle Case Study and Panel Discussion | Moderator: Robert H. Eckel, MD Discussants: Martha M. Funnell, MS, RN, CDE Lee M. Kaplan, MD, PhD Samuel Klein, MD Francesco Rubino, MD Frank M. Sacks, MD |
| 5:00pm | Closing Remarks | |
| 5:00pm - 6:00pm | 10th Annual Celebration/Exhibitor Showcase (Raffle) |
|
| 6:00pm - 7:00pm | Uncovering Generalized Lipodystrophy: Clinical Characteristics and Treatment Considerations Sponsored by Aegerion Pharmaceuticals |
Tamer Yacoub, MD Generalized Lipodystrophy Patient Advocate |
| 7:00pm - 9:00pm | Paving the Way to Patient Acceptance, Adherence and Satisfaction: The Role of Next-Generation Insulin Therapies Supported by an educational grant from Novo Nordisk, Inc. |
Matthew C. Riddle, MD (Chair) Anne L. Peters, MD Martha M. Funnell, MS, RN, CDE Daniel Einhorn, MD |
Saturday, October 24, 2015
On a mobile device? Drag the schedule to the right to view all the event details.
| 6:30am - 8:00am | The Evolution of Insulin Therapy: New Developments in Treatment, Technology, and Methods of Administration Supported by an educational grant from sanofi US |
Anne L. Peters, MD (Chair) Martin J. Abrahamson, MD Howard A. Wolpert, MD |
SESSION IV: DIABETES MANAGEMENT
| 8:00am - 8:10am | General Sessions Begin: Opening Remarks | Jay S. Skyler, MD |
| 8:10am - 8:45am | Type 2 Diabetes Management Update 2015 Focus on Noninsulin therapies | John B. Buse, MD, PhD |
| 8:45am - 9:10am | Insulin Therapy: The State-of-the-Science | Matthew C. Riddle, MD |
| 9:10am - 9:35am | Insulin Resistance and Polycystic Ovary Syndrome: Pathogenesis, Evaluation, and Treatment | Andrea E. Dunaif, MD |
| 9:35am - 9:50am | Morning Break |
|
| 9:50am - 10:15am | Advances in Diabetes Technology | Anne L. Peters, MD |
| 10:15am - 10:45am |
Keynote SessionInsulin and Beta Cell Replacement: From Secretion to Action |
Michael R. Rickels, MD, MS |
| 10:45am - 11:45am | Diabetes Panel and Cases | Moderator: Jay S. Skyler, MD Discussants: John B. Buse, MD, PhD Andrea E. Dunaif, MD Anne L. Peters, MD Michael R. Rickels, MD, MS Matthew C. Riddle, MD |
| 11:45am | Closing Remarks | Jay S. Skyler, MD |
Note: Agenda & Faculty are subject to change.
Back to 10th Annual CMHC Home
A division of Tarsus Medical owned by Tarsus Group
Cardiometabolic Health Congress.
All Rights Reserved.
